Search

Your search keyword '"Stief C"' showing total 422 results

Search Constraints

Start Over You searched for: Author "Stief C" Remove constraint Author: "Stief C" Database Unpaywall Remove constraint Database: Unpaywall
422 results on '"Stief C"'

Search Results

3. Oncologic outcomes of template vs. radio-guided salvage lymph node dissection for node-only recurrent prostate cancer: Results from a multi-institutional collaboration

9. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET: Results of a Multicenter, European Study

10. PD-0567 CT-based radiomic signatures to predict biochemical recurrence after salvage radiotherapy

11. First clinical results of [68Ga]Ga-FAPI-46 PET/CT in squamous penile cancer

14. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool

15. What is the optimal management of nodal oligorecurrent prostate cancer? results from a large series of patients treated with salvage lymph node dissection

19. What is the optimal management of nodal oligorecurrent prostate cancer? Results from a large series of patients treated with salvage lymph node dissection

20. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: A novel risk stratification tool

22. Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: clinical implications for multi-modal therapy

24. Priapismus

25. Priapismus

26. Harnblasenkarzinom

27. Harnblasenkarzinom

28. PO-1329 Longterm Biochemical Recurrence-Free Survival after PSMA-PET/CT–Based Salvage Radiotherapy

29. PH-0659 Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/CT era – a bi-institutional, retrospective analysis

31. Assessing the association between the template of pelvic salvage lymph node dissection for node-only recurrent prostate cancer and oncological outcomes. Results of a multi-institutional series

33. Definition and impact on oncologic outcomes of persistently elevated PSA after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Clinical Implications for multi-modal therapy

35. Identifying the optimal candidates for radiation therapy after salvage lymph node dissection for node-only recurrent prostate cancer after radical prostatectomy: Results from a multi-institutional collaboration

36. Fear of cancer recurrence in bladder cancer patients undergoing radical cystectomy with urinary diversion - Preliminary results from a prospective study (NCT04535921)

39. 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results

45. Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal approach

46. Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient stratification for tailored post-operative treatments

47. Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation according to each area of dissection

48. What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series

50. What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? Results from a large, multi-institutional series

Catalog

Books, media, physical & digital resources